image
Healthcare - Biotechnology - NASDAQ - US
$ 8.16
-8.36 %
$ 310 M
Market Cap
4.96
P/E
INCOME STATEMENT
211 M REVENUE
63.38%
47 M OPERATING INCOME
1586.75%
65.6 M NET INCOME
1081.69%
EFFICIENCY
Earnings Waterfall Entrada Therapeutics, Inc.
image
Revenue 211 M
Cost Of Revenue 3.77 M
Gross Profit 207 M
Operating Expenses 164 M
Operating Income 47 M
Other Expenses -18.6 M
Net Income 65.6 M
250m250m200m200m150m150m100m100m50m50m00211m(4m)207m(164m)47m19m66mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
REVENUE
Revenue 210.8 129.0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 3.8 99.9 1.9 1.1 0.3 0.1
Gross Profit 207.0 29.1 (1.9) (1.1) (0.3) (0.1)
OPERATING INCOME
Operating Expenses 163.8 132.2 97.2 51.1 26.7 11.8
Selling, General and Administrative Expenses 38.5 32.3 30.6 15.2 5.6 3.6
Research and Development Expenses 125.3 99.9 66.6 35.9 21.1 8.2
Operating Income 47.0 (3.2) (97.2) (51.1) (26.7) (11.8)
PRE-TAX INCOME
Interest Income Expense 0 0 2.6 0 0 0
Total Other Income 19.5 15.2 2.6 31 K 0.1 6.7
Pre-Tax Income 66.5 12.1 (94.6) (51.2) (26.5) (5.1)
NET INCOME
Tax Provision 0.9 18.7 (7.2) (1.1) (0.1) (0.5)
Net Income 65.6 (6.7) (87.5) (50.1) (26.4) (4.6)
EPS 1.76 0.2 2.79 1.6 0.84 0.15